⏳ Fetching live dividend data...
Home › Calculator › OPGN Dividend Calculator 2026
OpGen, Inc. · OTC
Price: $23.91 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in OPGN → $1382.27M in 10 years · $113,859,626.01/month
OpGen, Inc. is a precision medicine company dedicated to developing and commercializing advanced molecular microbiology solutions for both U.S. and international markets. Its comprehensive product suite includes the Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test designed to pinpoint various bacterial nucleic acids and genetic markers of antimicrobial resistance (AMR) from bacterial colonies sourced from diverse specimen types. The company also offers Curetis CE-IVD-marked polymerase chain reaction (PCR)-based test kits for SARS-CoV-2 detection. Beyond diagnostics, OpGen provides sophisticated platforms like the ARES Technology Platform. This platform features the ARES reference database, which leverages next-generation sequencing technology and artificial intelligence-powered bioinformatics to predict antibiotic response for antimicrobial resistance. Another core offering is the Unyvero Platform, an automated, sample-to-answer molecular diagnostics system. It seamlessly integrates automated sample preparation, analysis, and identification of disease-relevant pathogens and their associated antibiotic resistance markers. Fundamentally, OpGen harnesses molecular diagnostics and informatics to actively combat infectious diseases. The company empowers clinicians by providing crucial insights into life-threatening infections, thereby enhancing patient outcomes and significantly slowing the spread of infections caused by multidrug-resistant microorganisms. In a notable collaboration, OpGen is partnered with the New York State Department of Health and ILÚM Health Solutions, LLC, to establish a research program. This initiative focuses on the detection, tracking, and effective management of antimicrobial-resistant infections within healthcare institutions. Established in 2001, OpGen, Inc. maintains its corporate headquarters in Rockville, Maryland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OPGN position with:
Real after-tax yield depends on where you live and how you hold OPGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 8.36% | 5.56% | $836 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 7.11% | 4.31% | $711 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6.69% | 3.89% | $669 / yr |
| 🇬🇧 UK ISA | 0% | 8.36% | 5.56% | $836 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7.63% | 4.83% | $763 / yr |
| 🇨🇦 TFSA | 0% | 8.36% | 5.56% | $836 / yr |
| 🇨🇦 CA Taxable | 25% | 6.27% | 3.47% | $627 / yr |
| 🇦🇺 Super (pension) | 15% | 7.11% | 4.31% | $711 / yr |
| 🇦🇺 AU Taxable | 30% | 5.85% | 3.05% | $585 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6.16% | 3.36% | $616 / yr |
| 🇫🇷 FR Taxable | 30% | 5.85% | 3.05% | $585 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
OPGN pays quarterly — 4 times per year. Next ex-div: TBD.
How OPGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OPGN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-02-23 | 5,555 | — | — | ||
| A-Award | 2026-02-23 | 2,778 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OPGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
OpGen, Inc. (OPGN) is currently trading at $23.91, 96% below its 52-week high. The current dividend yield is 8.36% based on an annual payout of $2.00 per share.
OpGen, Inc. (OPGN) is a healthcare stock currently trading at $23.91 with a dividend yield of 8.36%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →